Efficacy of anti-insulin like growth factor I receptor (IGF-IR) monoclonal antibody cixutumumab in mesothelioma is highly correlated with IGF-IR sites/cell

par Kalra, Neetu, Zhang, Jingli, Yu, Yunkai, Ho, Mitchell, Merino, Maria, Cao, Liang, Hassan, Raffit
Publié 2012

Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors

par KALRA, NEETU, ASHAI, ALI, XI, LIQIANG, ZHANG, JINGLI, AVITAL, ITZHAK, RAFFELD, MARK, HASSAN, RAFFIT
Publié dans Oncol Rep (2012)

Potential of Diallyl Sulfide Bearing pH-Sensitive Liposomes in Chemoprevention Against DMBA-Induced Skin Papilloma

par Khan, Arif, Shukla, Yogeshwer, Kalra, Neetu, Alam, Maroof, Ahmad, Manzoor Gatoo, Hakim, Seema Rashid, Owais, Mohammad
Publié 2007

Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma

par Kalra, Neetu, Zhang, Jingli, Thomas, Anish, Xi, Liqiang, Cheung, Mitchell, Talarchek, Jacqueline, Burkett, Sandra, Tsokos, Maria G, Chen, Yuanbin, Raffeld, Mark, Miettinen, Markku, Pastan, Ira, Testa, Joseph R, Hassan, Raffit
Publié dans BMC Cancer (2015)